Chiron Real Estate
Acquires and leases medical office buildings and surgical hospitals to regional health systems.
Something off on this page? Send us feedback.
Profile
Owns purpose-built medical office buildings, inpatient rehab facilities, and surgical hospitals, leasing them under mostly triple-net terms to regional and national health systems and physician groups. Rent is diversified across many tenants and states, with no single tenant contributing more than a small share of annualized income.
Owns purpose-built healthcare real estate anchored on outpatient medical office buildings, with additional exposure to inpatient rehabilitation facilities, surgical hospitals, and acute-care and behavioral hospitals. The portfolio spans roughly 190 buildings, leased mostly under triple-net terms to regional and national health systems and physician groups across dozens of states.
No single tenant contributes more than a small share of rent, and multi-year leases carry built-in annual escalators, producing a base of long-duration, contractually growing income.
The company began as a Nevada shell before re-forming into a Maryland real estate investment trust and listing on the New York Stock Exchange in 2016. It later internalized its external manager and, under new leadership, renamed itself from Global Medical REIT to Chiron Real Estate, broadening its mandate into adjacent essential-healthcare property types such as senior living.
Company facts
Key statistics
Year to date +5.5% · Average volume (30d) 86.4K
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Prior rating | Rating | Prior target | Target |
|---|---|---|---|---|---|---|
| Jul 12, 2026 | BMO Capital | Reiterate | Market Perform | $39 | $40 | |
| Jul 1, 2026 | Industrial Alliance Securities | Target | $40 | $43 | ||
| May 18, 2026 | BMO Capital | Reiterate | Market Perform | $39 | ||
| May 7, 2026 | Industrial Alliance Securities | Target | $40 | |||
| May 7, 2026 | Compass Point | Downgrade | Buy | Neutral | $38 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 5, 2026Q2 FY26 | −$0.24 | $4.78 | +2,134.0% | $37.6M | $37.1M | −1.5% | +1.14% |
| May 6, 2026Q1 FY26 | $0.01 | $0.97 | +19,300.0% | $38.2M | $38.0M | −0.5% | −9.24% |
| Feb 25, 2026Q4 FY25 | $0.07 | $0.97 | +1,392.3% | $37.1M | $38.2M | +2.9% | −1.61% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $37.9M | $41.3M | $40.6M | $38.4M | $38.1M | $39.7M | |
| Gross profit | $2.6M | $2.5M | $2.3M | −$35.0K | −$840.0K | −$839.0K | |
| Operating income | $12.9M | $11.7M | $12.5M | $9.4M | $8.9M | $9.2M | |
| Net income | $3.6M | $655.0K | −$4.5M | −$5.5M | $1.7M | $66.3M | |
| Diluted EPS | $0.16 | $0.05 | −$0.45 | −$0.55 | $0.13 | $4.78 | |
| Gross margin | 7.0% | 6.0% | 5.7% | -0.1% | -2.2% | -2.1% | |
| Operating margin | 33.9% | 28.4% | 30.7% | 24.5% | 23.4% | 23.2% |
Fiscal years (4-quarter sums)FY18 $53.2M · FY19 $70.6M · FY20 $93.7M · FY24 $138.4M · FY25 $158.1M
Balance sheet, Jun 30, 2026Cash & short-term investments $10.7M · Total debt $636.9M · Total assets $1.37B · Shareholders' equity $656.9M
Dividends
Last cut to $0.16 from $0.25 in Jun 2026. To collect a payout, hold shares through the close before the ex-date.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Aug 20, 2026 | Aug 20 | Sep 18 | $0.16 | |
| Jul 20, 2026 | Jul 20 | Aug 14 | $0.16 | |
| Jun 22, 2026 | Jun 22 | Jul 17 | $0.16 | cut from $0.25 |
| May 20, 2026 | May 20 | Jun 12 | $0.25 | |
| Apr 20, 2026 | Apr 20 | May 15 | $0.25 | |
| Mar 20, 2026 | Mar 20 | Apr 17 | $0.25 | cut from $0.75 |
| Dec 19, 2025 | Dec 19 | Jan 9 | $0.75 | |
| Sep 29, 2025 | Sep 29 | Oct 15 | $0.75 |
Ownership
Shares outstanding 13.23M · Float 12.30M · 93.0% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| Prudential Financial Inc | 3.43M | 5.10% | 13G | May 15, 2025 |
| Vanguard Portfolio Management | 666.5K | 5.03% | 13G | Jul 31, 2026 |
| Charles Fitzgerald · director | 138.9K | 1.05% | Form 4 | Aug 13, 2026 |
| Mark Okey Jr Decker · director, officer: CEO and President | 75.2K | 0.57% | Form 4 | Aug 13, 2026 |
| Aaron Robert Roseth · director, officer: COO | 13.5K | 0.10% | Form 4 | Aug 13, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 17, 2026 | Matthew Fitzsimmons Whitlock | officer: Chief Investment Officer | +500 | $36.38 |
| Aug 14, 2026 | Matthew Fitzsimmons Whitlock | officer: Chief Investment Officer | +500 | $37.21 |
| Aug 11, 2026 | Mark Okey Jr Decker | director, officer: CEO and President | +7,425 | $35.93 |
| Aug 12, 2026 | Aaron Robert Roseth | director, officer: COO | +13,500 | $36.73 |
| Aug 11, 2026 | Charles Fitzgerald | director | +14,000 | $35.78 |
Peers
- Healthcare Realty
Largest US pure-play outpatient MOB REIT, ~$10.3B portfolio, 502 properties
- Healthpeak Properties
Large-cap diversified healthcare REIT, ~55% NOI in outpatient medical
- Medical Properties Trust
Larger, hospital-focused, global net-lease REIT also hit by Steward's collapse
- Ventas
Mega-cap diversified healthcare REIT with 409-property outpatient medical arm
- American Healthcare REIT
Diversified healthcare REIT: outpatient medical, senior housing, skilled nursing
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Chiron Real Estate | $37.19 | +0.84% | $487.3M | 9.4 | — | 3.1 | — |
| Healthcare Realty | $18.99 | 0.00% | $6.66B | — | 275.4 | 5.8 | −5.3% |
| Healthpeak Properties | $20.79 | −0.79% | $14.45B | 59.9 | 101.1 | 4.9 | +8.0% |
| Medical Properties Trust | $4.09 | −0.35% | $2.45B | — | 75.7 | 2.4 | +7.9% |
| Ventas | $91.58 | −0.25% | $44.63B | 170.0 | 130.6 | 6.9 | +21.7% |
| American Healthcare REIT | $55.53 | −0.04% | $11.48B | 81.6 | 79.5 | 4.6 | +23.7% |
| Median | 81.6 | 101.1 | 4.9 | +8.0% |